Successful use of empagliflozin in medically refractory post-bariatric surgery hypoglycaemia

Intern Med J. 2024 May;54(5):836-837. doi: 10.1111/imj.16401.
No abstract available

Publication types

  • Letter
  • Case Reports

MeSH terms

  • Bariatric Surgery* / adverse effects
  • Benzhydryl Compounds* / adverse effects
  • Benzhydryl Compounds* / therapeutic use
  • Diabetes Mellitus, Type 2 / drug therapy
  • Female
  • Glucosides* / adverse effects
  • Glucosides* / therapeutic use
  • Humans
  • Hypoglycemia* / chemically induced
  • Hypoglycemia* / drug therapy
  • Male
  • Middle Aged
  • Postoperative Complications / drug therapy
  • Sodium-Glucose Transporter 2 Inhibitors / adverse effects
  • Sodium-Glucose Transporter 2 Inhibitors / therapeutic use
  • Treatment Outcome

Substances

  • empagliflozin